Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 2 (2005), Issue 7 (July)

1. Patients' choices for the self-treatment of pain.
   Appl Nurs Res, 18(2): 90-6. [Abstract] [Full-text]
2. Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
   Int J Clin Oncol, 10(3): 204-7. [Abstract] [Full-text]
3. Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.
   Int J Clin Oncol, 10(3): 157-64. [Abstract] [Full-text]
4. Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection.
   AIDS Res Hum Retroviruses, 21(6): 527-36. [Abstract] [Full-text]
5. Predictors of changes in health-related quality of life among men with HIV infection in the HAART era.
   AIDS Patient Care STDS, 19(6): 395-405. [Abstract] [Full-text]
6. Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: a pilot study.
   AIDS Patient Care STDS, 19(6): 384-94. [Abstract] [Full-text]
7. Effects of hormone replacement on progression of coronary calcium as measured by electron beam tomography.
   J Womens Health (Larchmt), 14(5): 410-7. [Abstract] [Full-text]
8. Correlates of prescription drug use during pregnancy.
   J Womens Health (Larchmt), 14(5): 401-9. [Abstract] [Full-text]
9. Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
   Acta Haematol, 114(1): 26-40. [Abstract] [Full-text]
10. Sleep disturbance and depression as barriers to adherence.
    Clin Nurs Res, 14(3): 273-93. [Abstract] [Full-text]
11. Enhancement of 5-fluorouracil sensitivity by an rTS signaling mimic in H630 colon cancer cells.
    Cancer Res, 65(13): 5917-24. [Abstract] [Full-text]
12. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis.
    Cancer Res, 65(13): 5848-56. [Abstract] [Full-text]
13. Sexual activity and function in postmenopausal women with heart disease.
    Obstet Gynecol, 106(1): 121-7. [Abstract] [Full-text]
14. Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy.
    J Clin Oncol, 23(19): 4399-405. [Abstract] [Full-text]
15. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS.
    J Clin Oncol, 23(19): 4372-80. [Abstract] [Full-text]
16. Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.
    Lancet Oncol, 6(7): 459-68. [Abstract] [Full-text]
17. Post-operative adjuvant chemoradiotherapy with carboplatin and 5-fluorouracil for primary branchiogenic carcinoma.
    J Laryngol Otol, 119(6): 467-9. [Abstract] [Full-text]
18. Enzymatic characterization of lipid-based drug delivery systems.
    Int J Pharm, 298(2): 328-32. [Abstract] [Full-text]
19. Cholesterol-bile salt vesicles as potential delivery vehicles for drug and vaccine delivery.
    Int J Pharm, 298(2): 339-43. [Abstract] [Full-text]
20. Strategies for cytosolic delivery of liposomal macromolecules.
    Int J Pharm, 298(2): 305-9. [Abstract] [Full-text]
21. Novel anhydrous emulsions: formulation as controlled release vehicles.
    Int J Pharm, 298(2): 367-71. [Abstract] [Full-text]
22. A methodology to study intracellular distribution of nanoparticles in brain endothelial cells.
    Int J Pharm, 298(2): 310-4. [Abstract] [Full-text]
23. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Ophthalmology, 112(7): 1227-31. [Abstract] [Full-text]
24. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
    J Clin Oncol, 23(19): 4265-74. [Abstract] [Full-text]
25. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
    Dis Colon Rectum, 48(7): 1372-9. [Abstract] [Full-text]
26. Nanoencapsulation of a crystalline drug.
    Int J Pharm, 298(2): 323-7. [Abstract] [Full-text]
27. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
    Int J Pharm, 298(2): 274-92. [Abstract] [Full-text]
28. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    J Clin Oncol, 23(19): 4430-8. [Abstract] [Full-text]
29. A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.
    Blood, 106(2): 454-7. [Abstract] [Full-text]
30. Survival after recurrence of Ewing's sarcoma family of tumors.
    J Clin Oncol, 23(19): 4354-62. [Abstract] [Full-text]
31. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children.
    Blood, 106(2): 447-53. [Abstract] [Full-text]
32. Thromboembolic cerebral ischaemic attack complicating cardiac catheterization. Successful local thrombolytic therapy with reduced dose rt-PA.
    Z Kardiol, 94(7): 474-8. [Abstract] [Full-text]
33. Delayed prescription may reduce the use of antibiotics for acute otitis media: a prospective observational study in primary care.
    Arch Pediatr Adolesc Med, 159(7): 679-84. [Abstract] [Full-text]
34. Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy.
    Arch Pediatr Adolesc Med, 159(7): 651-6. [Abstract] [Full-text]
35. Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.
    J Thorac Cardiovasc Surg, 130(1): 125-30. [Abstract] [Full-text]
36. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
    Skin Res Technol, 11(3): 201-4. [Abstract] [Full-text]
37. A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours.
    Br J Cancer, 93(1): 54-9. [Abstract] [Full-text]
38. Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer.
    Br J Cancer, 93(1): 60-9. [Abstract] [Full-text]
39. Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
    Br J Cancer, 93(1): 29-34. [Abstract] [Full-text]
40. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.
    Cancer, 104(2): 282-9. [Abstract] [Full-text]
41. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
    Cancer, 104(2): 367-73. [Abstract] [Full-text]
42. Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
    Cancer, 104(2): 345-53. [Abstract] [Full-text]
43. Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.
    Cancer Immunol Immunother, 54(9): 926-31. [Abstract] [Full-text]
44. Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer.
    Clin Cancer Res, 11(13): 5051s-5056s. [Abstract] [Full-text]
45. Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer.
    Clin Cancer Res, 11(13): 5045s-5050s. [Abstract] [Full-text]
46. The role of targeted agents in adjuvant therapy for non-small cell lung cancer.
    Clin Cancer Res, 11(13): 5027s-5029s. [Abstract] [Full-text]
47. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Clin Cancer Res, 11(13): 5022s-5026s. [Abstract] [Full-text]
48. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
    Clin Cancer Res, 11(13): 5017s-5021s. [Abstract] [Full-text]
49. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
    Clin Cancer Res, 11(13): 5011s-5016s. [Abstract] [Full-text]
50. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.
    Eur J Haematol, 75(2): 124-9. [Abstract] [Full-text]
51. Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy.
    Eur J Haematol, 75(2): 116-23. [Abstract] [Full-text]
52. Drug errors, qualitative research and some reflections on ethics.
    J Clin Nurs, 14(7): 869-75. [Abstract] [Full-text]
53. Chemotherapy for non-small cell lung cancer in elderly patients.
    Chest, 128(1): 132-9. [Abstract] [Full-text]
54. Systemic therapy for metastatic colorectal cancer: current options, current evidence.
    J Clin Oncol, 23(20): 4553-60. [Abstract] [Full-text]
55. Blends of aqueous polymer dispersions used for pellet coating: importance of the particle size.
    J Control Release, 105(3): 226-39. [Abstract] [Full-text]
56. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters.
    J Clin Endocrinol Metab, 90(7): 3978-82. [Abstract] [Full-text]
57. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine.
    J Clin Endocrinol Metab, 90(7): 4057-62. [Abstract] [Full-text]
58. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
    J Clin Endocrinol Metab, 90(7): 3946-55. [Abstract] [Full-text]
59. Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men.
    J Clin Endocrinol Metab, 90(7): 3989-94. [Abstract] [Full-text]
60. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.
    J Clin Endocrinol Metab, 90(7): 3877-85. [Abstract] [Full-text]
61. The drug utilization patterns of Hong Kong Chinese adults.
    Complement Ther Clin Pract, 11(3): 190-9. [Abstract] [Full-text]
62. Pharmacogenomics: questions and concerns.
    Curr Med Res Opin, 21(7): 1041-7. [Abstract] [Full-text]
63. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors.
    Int J STD AIDS, 16(7): 475-8. [Abstract] [Full-text]
64. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    J Surg Oncol, 91(1): 84-9. [Abstract] [Full-text]
65. Effective nasal influenza vaccine delivery using chitosan.
    Vaccine, 23(35): 4367-74. [Abstract] [Full-text]
66. Detection and prevention of medication errors using real-time bedside nurse charting.
    J Am Med Inform Assoc, 12(4): 390-7. [Abstract] [Full-text]
67. Comprehensive analysis of a medication dosing error related to CPOE.
    J Am Med Inform Assoc, 12(4): 377-82. [Abstract] [Full-text]
68. Implementing a commercial rule base as a medication order safety net.
    J Am Med Inform Assoc, 12(4): 383-9. [Abstract] [Full-text]
69. Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care.
    J Am Med Inform Assoc, 12(4): 398-402. [Abstract] [Full-text]
70. Clinical decision support in electronic prescribing: recommendations and an action plan: report of the joint clinical decision support workgroup.
    J Am Med Inform Assoc, 12(4): 365-76. [Abstract] [Full-text]
71. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy.
    Australas J Dermatol, 46(3): 196-8. [Abstract] [Full-text]
72. Factors that influence prescribing within a therapeutic drug class.
    J Eval Clin Pract, 11(4): 357-65. [Abstract] [Full-text]
73. Symptom experience after discontinuing use of estrogen plus progestin.
    JAMA, 294(2): 183-93. [Abstract] [Full-text]
74. Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging.
    Int J Gynecol Cancer, 15(4): 601-5. [Abstract] [Full-text]
75. Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate.
    Ann Rheum Dis, 64(8): 1132-6. [Abstract] [Full-text]
76. Menopausal hormones and risk of ovarian cancer.
    Am J Obstet Gynecol, 193(1): 76-82. [Abstract] [Full-text]
77. Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys.
    Am J Obstet Gynecol, 193(1): 58-63. [Abstract] [Full-text]
78. Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine.
    Curr Eye Res, 30(7): 601-12. [Abstract] [Full-text]
79. Competitive quenching: a possible novel approach in protecting RPE cells from damage during PDT.
    Curr Eye Res, 30(4): 269-77. [Abstract] [Full-text]
80. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study.
    J Cosmet Laser Ther, 7(1): 21-4. [Abstract] [Full-text]
81. Flomoxef sodium and levofloxacin concentrations in aqueous humor.
    Ocul Immunol Inflamm, 13(2): 229-34. [Abstract] [Full-text]
82. Subretinal neovascular membranes complicating uveitis: frequency, treatments, and visual outcome.
    Ocul Immunol Inflamm, 13(2): 219-24. [Abstract] [Full-text]
83. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
    Ocul Immunol Inflamm, 13(2): 213-8. [Abstract] [Full-text]
84. Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome.
    Leuk Lymphoma, 46(7): 1091-5. [Abstract] [Full-text]
85. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
    Leuk Lymphoma, 46(7): 1085-9. [Abstract] [Full-text]
86. Granulocytic sarcoma of the heart: extramedullary relapse of acute myeloblastic leukemia after allogeneic stem cell transplantation successfully treated by chemotherapy alone.
    Leuk Lymphoma, 46(7): 1081-4. [Abstract] [Full-text]
87. Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
    Leuk Lymphoma, 46(7): 1075-9. [Abstract] [Full-text]
88. Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy.
    Leuk Lymphoma, 46(7): 1023-8. [Abstract] [Full-text]
89. Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease.
    Leuk Lymphoma, 46(7): 1017-22. [Abstract] [Full-text]
90. Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.
    Leuk Lymphoma, 46(7): 1007-16. [Abstract] [Full-text]
91. Successful treatment of extranodal Hodgkin's lymphoma in a patient with longstanding hairy cell leukemia.
    Leuk Lymphoma, 46(5): 765-9. [Abstract] [Full-text]
92. Prolonged treatment response in aggressive natural killer cell leukemia.
    Leuk Lymphoma, 46(5): 757-63. [Abstract] [Full-text]
93. Cerebral thrombotic complications in adolescent leukemia/lymphoma patients treated with L-asparaginase-containing chemotherapy.
    Leuk Lymphoma, 46(5): 729-35. [Abstract] [Full-text]
94. Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma.
    Leuk Lymphoma, 46(4): 567-9. [Abstract] [Full-text]
95. Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP.
    Leuk Lymphoma, 46(4): 549-52. [Abstract] [Full-text]
96. R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy.
    Leuk Lymphoma, 46(4): 541-7. [Abstract] [Full-text]
97. Intrauterine levonorgestrel delivered by a frameless system, combined with systemic estrogen: acceptability and endometrial safety after 3 years of use in peri- and postmenopausal women.
    Gynecol Endocrinol, 20(6): 336-42. [Abstract] [Full-text]
98. Menopause and dry eye. A possible relationship.
    Gynecol Endocrinol, 20(5): 289-98. [Abstract] [Full-text]
99. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
    Gynecol Endocrinol, 20(5): 274-8. [Abstract] [Full-text]
100. Percutaneous administration of testosterone gel in postmenopausal women--a pharmacological study.
     Gynecol Endocrinol, 20(5): 243-8. [Abstract] [Full-text]
101. Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels.
     Gynecol Endocrinol, 20(4): 227-35. [Abstract] [Full-text]
102. Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers.
     Gynecol Endocrinol, 20(4): 221-6. [Abstract] [Full-text]
103. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
     Gynecol Endocrinol, 20(4): 209-12. [Abstract] [Full-text]
104. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
     Gynecol Endocrinol, 20(3): 176-82. [Abstract] [Full-text]
105. Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model.
     J Periodontol, 76(7): 1100-5. [Abstract] [Full-text]
106. Rational design of an EGF-IL18 fusion protein: implication for developing tumor therapeutics.
     Biochem Biophys Res Commun, 334(1): 157-61. [Abstract] [Full-text]
107. Glycerol hyperhydration: physiological responses during cold-air exposure.
     J Appl Physiol, 99(2): 515-21. [Abstract] [Full-text]
108. Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft.
     Cancer Res, 65(14): 6388-93. [Abstract] [Full-text]
109. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
     Cancer Res, 65(14): 6371-9. [Abstract] [Full-text]
110. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
     Cancer Res, 65(14): 6364-70. [Abstract] [Full-text]
111. Popliteal aneurysms: controversies in their management.
     Am J Surg, 190(2): 314-8. [Abstract] [Full-text]
112. The effect of multidrug chemotherapy on bone graft augmented prosthesis fixation.
     J Orthop Res, 23(4): 795-801. [Abstract] [Full-text]
113. 'Smart' delivery systems for biomolecular therapeutics.
     Orthod Craniofac Res, 8(3): 219-25. [Abstract] [Full-text]
114. Hormone replacement therapy: one-year follow up of DNA damage.
     Mutat Res, 585(1): 14-20. [Abstract] [Full-text]
115. Intact human holo-transferrin interaction with oxaliplatin.
     Rapid Commun Mass Spectrom, 19(14): 1956-62. [Abstract] [Full-text]
116. Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review.
     Hum Reprod, 20(8): 2052-60. [Abstract] [Full-text]
117. The quality of chemotherapy and its quality assurance.
     Eur J Surg Oncol, 31(6): 656-66. [Abstract] [Full-text]
118. Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma.
     Hum Reprod, 20(8): 2247-9. [Abstract] [Full-text]
119. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
     Eur J Cancer, 41(11): 1588-96. [Abstract] [Full-text]
120. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period.
     Eur J Cancer, 41(11): 1570-83. [Abstract] [Full-text]
121. Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer.
     Eur J Cancer, 41(11): 1551-9. [Abstract] [Full-text]
122. Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients.
     Diabet Med, 22(8): 1037-46. [Abstract] [Full-text]
123. Effectiveness of chemotherapy in melanotic neurectodermal tumor of infancy.
     Pediatr Hematol Oncol, 22(3): 199-206. [Abstract] [Full-text]
124. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
     Pediatr Hematol Oncol, 22(3): 189-98. [Abstract] [Full-text]
125. The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC).
     Eur J Cancer, 41(11): 1542-6. [Abstract] [Full-text]
126. Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial.
     Eur J Cancer, 41(11): 1560-9. [Abstract] [Full-text]
127. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
     J Natl Cancer Inst, 97(14): 1080-3. [Abstract] [Full-text]
128. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
     Cancer Epidemiol Biomarkers Prev, 14(7): 1724-31. [Abstract] [Full-text]
129. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas.
     Int J Radiat Oncol Biol Phys, 62(5): 1357-62. [Abstract] [Full-text]
130. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
     Int J Radiat Oncol Biol Phys, 62(5): 1345-50. [Abstract] [Full-text]
131. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
     Br J Dermatol, 153(1): 103-12. [Abstract] [Full-text]
132. Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.
     Br J Cancer, 93(2): 190-4. [Abstract] [Full-text]
133. A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
     Br J Cancer, 93(2): 178-84. [Abstract] [Full-text]
134. Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).
     Br J Cancer, 93(2): 185-9. [Abstract] [Full-text]
135. Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin.
     Jpn J Clin Oncol, 35(7): 417-9. [Abstract] [Full-text]
136. Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer.
     Jpn J Clin Oncol, 35(7): 380-5. [Abstract] [Full-text]
137. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
     J Clin Oncol, 23(21): 4602-8. [Abstract] [Full-text]
138. Bioavailability of vitamin B using a small-volume nebulizer ophthalmic drug delivery system.
     Clin Experiment Ophthalmol, 33(4): 402-7. [Abstract] [Full-text]
139. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
     Leukemia, 19(8): 1355-60. [Abstract] [Full-text]
140. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
     J Clin Oncol, 23(21): 4634-42. [Abstract] [Full-text]
141. Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery.
     Anesth Analg, 101(2): 601-5. [Abstract] [Full-text]
142. Comorbidity and medication load in adult asthmatics.
     Scand J Prim Health Care, 23(2): 88-94. [Abstract] [Full-text]
143. Effect of chemotherapy on circulating gastrointestinal hormone levels in ovarian cancer patients: relationship to nausea and vomiting.
     Scand J Gastroenterol, 40(6): 654-61. [Abstract] [Full-text]
144. Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin's lymphoma.
     Scand J Gastroenterol, 40(5): 604-6. [Abstract] [Full-text]
145. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
     J Drug Target, 13(3): 189-97. [Abstract] [Full-text]
146. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns.
     J Drug Target, 13(3): 179-87. [Abstract] [Full-text]
147. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
     J Drug Target, 13(3): 151-9. [Abstract] [Full-text]
148. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure.
     AIDS Care, 17(6): 773-83. [Abstract] [Full-text]
149. Knowledge and acceptability of HAART among TB patients in Durban, South Africa.
     AIDS Care, 17(6): 767-72. [Abstract] [Full-text]
150. Back to work: correlates of employment among persons receiving highly active antiretroviral therapy.
     AIDS Care, 17(6): 740-6. [Abstract] [Full-text]
151. Trends and predictors of HIV-positive community attachment among PLWHA.
     AIDS Care, 17(5): 589-600. [Abstract] [Full-text]
152. An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART.
     AIDS Care, 17(5): 579-88. [Abstract] [Full-text]
153. Determinants of HAART discontinuation among injection drug users.
     AIDS Care, 17(5): 539-49. [Abstract] [Full-text]
154. Engineered gene over-expression as a method of drug target identification.
     Biochem Biophys Res Commun, 334(2): 555-60. [Abstract] [Full-text]
155. Defective rev response element (RRE) and rev gene in HAART treated AIDS patients with discordance between viral load and CD4+ T-cell counts.
     J Clin Virol, 33(4): 324-7. [Abstract] [Full-text]
156. Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
     J Antimicrob Chemother, 56(1): 190-5. [Abstract] [Full-text]
157. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
     Biol Blood Marrow Transplant, 11(8): 637-46. [Abstract] [Full-text]
158. A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation.
     Biol Blood Marrow Transplant, 11(8): 627-36. [Abstract] [Full-text]
159. Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes.
     Infect Dis Obstet Gynecol, 13(1): 5-10. [Abstract] [Full-text]
160. Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure.
     Dermatol Clin, 23(3): 443-55, vi. [Abstract] [Full-text]
161. Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer.
     Lancet, 366(9482): 318-20. [Abstract] [Full-text]
162. Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
     Leuk Res, 29(9): 1003-7. [Abstract] [Full-text]
163. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
     J Med Virol, 77(1): 29-38. [Abstract] [Full-text]
164. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
     J Med Virol, 77(1): 23-8. [Abstract] [Full-text]
165. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
     J Surg Oncol, 91(2): 107-11. [Abstract] [Full-text]
166. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
     J Surg Oncol, 91(2): 97-101. [Abstract] [Full-text]
167. The virosome concept for influenza vaccines.
     Vaccine, 23: S26-38. [Abstract] [Full-text]
168. Clinical experience with inactivated, virosomal influenza vaccine.
     Vaccine, 23: S39-49. [Abstract] [Full-text]
169. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.
     Cancer, 104(3): 525-31. [Abstract] [Full-text]
170. 2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome.
     Cancer, 104(3): 541-6. [Abstract] [Full-text]
171. Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer.
     Gynecol Oncol, 98(2): 203-10. [Abstract] [Full-text]
172. Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.
     Gynecol Oncol, 98(2): 267-73. [Abstract] [Full-text]
173. Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study.
     Cancer, 104(3): 611-7. [Abstract] [Full-text]
174. Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).
     Cancer, 104(3): 555-60. [Abstract] [Full-text]
175. The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.
     Am J Ophthalmol, 140(1): 83-7. [Abstract] [Full-text]
176. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
     Cancer, 104(3): 532-40. [Abstract] [Full-text]
177. Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration.
     Am J Ophthalmol, 140(1): 23-8. [Abstract] [Full-text]
178. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention.
     J Pain Symptom Manage, 30(1): 75-9. [Abstract] [Full-text]
179. Retrospective observational case-control study comparing prehospital thrombolytic therapy for ST-elevation myocardial infarction with in-hospital thrombolytic therapy for patients from same area.
     Emerg Med J, 22(8): 582-5. [Abstract] [Full-text]
180. A systematic review and meta-analysis of misuse of antibiotic therapies in the community.
     Int J Antimicrob Agents, 26(2): 106-13. [Abstract] [Full-text]
181. Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors.
     Cancer Chemother Pharmacol, 56(4): 329-36. [Abstract] [Full-text]
182. Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin.
     Cancer Chemother Pharmacol, 56(4): 337-43. [Abstract] [Full-text]
183. Applications of aminolevulinic Acid-based photodynamic therapy in cosmetic facial plastic practices.
     Facial Plast Surg, 21(2): 110-6. [Abstract] [Full-text]
184. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
     Can J Ophthalmol, 40(2): 170-4. [Abstract] [Full-text]
185. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
     Nature, 436(7050): 568-72. [Abstract] [Full-text]
186. Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.
     Antimicrob Agents Chemother, 49(8): 3361-6. [Abstract] [Full-text]
187. Chemotherapy in advanced non-small cell lung cancer.
     Semin Respir Crit Care Med, 26(3): 304-13. [Abstract] [Full-text]
188. The role of adjuvant chemotherapy for non-small cell lung cancer.
     Semin Respir Crit Care Med, 26(3): 298-303. [Abstract] [Full-text]
189. Treatment of locally advanced non-small cell lung cancer with combination of chemotherapy and radiation.
     Semin Respir Crit Care Med, 26(3): 273-7. [Abstract] [Full-text]
190. Thromboembolism during hormone therapy in Japanese women.
     Semin Thromb Hemost, 31(3): 272-80. [Abstract] [Full-text]
191. Failure of thromboprophylaxis in pregnancy caused by dual deficiencies of protein s and protein C.
     Semin Thromb Hemost, 31(3): 261-5. [Abstract] [Full-text]
192. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
     J Clin Oncol, 23(22): 5224-8. [Abstract] [Full-text]
193. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
     J Clin Oncol, 23(22): 5166-70. [Abstract] [Full-text]
194. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
     J Clin Oncol, 23(22): 4897-904. [Abstract] [Full-text]
195. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
     Womens Health Issues, 15(4): 187-95. [Abstract] [Full-text]
196. Neonatal foal diarrhea.
     Vet Clin North Am Equine Pract, 21(2): 295-312, vi. [Abstract] [Full-text]
197. Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid.
     Cancer Lett, 227(1): 39-48. [Abstract] [Full-text]
198. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
     J Clin Oncol, 23(22): 4876-80. [Abstract] [Full-text]
199. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
     J Clin Oncol, 23(22): 4881-7. [Abstract] [Full-text]
200. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
     J Clin Oncol, 23(22): 4888-96. [Abstract] [Full-text]
201. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
     J Clin Oncol, 23(22): 5027-33. [Abstract] [Full-text]
202. Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy.
     J Clin Oncol, 23(22): 5217-23. [Abstract] [Full-text]
203. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
     J Clin Oncol, 23(22): 4991-8. [Abstract] [Full-text]
204. Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.
     J Clin Oncol, 23(22): 4856-65. [Abstract] [Full-text]
205. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.
     J Clin Oncol, 23(22): 4866-75. [Abstract] [Full-text]
206. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).
     J Clin Oncol, 23(22): 4963-74. [Abstract] [Full-text]

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.